Dias-Barbosa, Carla
Matos, Rodolfo https://orcid.org/0000-0003-2683-4970
Vernon, Margaret
Carney, Colleen E.
Krystal, Andrew
Puelles, Jorge
Article History
Received: 5 April 2020
Accepted: 3 November 2020
First Online: 23 November 2020
Change Date: 29 December 2020
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via the original article.
Ethics approval and consent to participate
: Adult participants had to provide written informed consent prior to study procedures. Adolescent participants had to provide informed assent, and their parent or legal guardian had to provide written permission for their child to participate beforehand. All participants also had to consent to being audio recorded during the discussions. All recruitment procedures complied with current Health Insurance Portability and Accountability Act regulations in the US. Evidera obtained institutional review board approval of the study protocol in the US prior to participant recruitment.
: Not applicable.
: AK reports research funding from the National Institutes of Health (NIH), Patient-Centered Outcomes Research Institute (PCORI), Janssen, Jazz, Axsome and Reveal Biosensors, as well as consulting fees from Eisai, Ferring, Galderma, Harmony Biosciences, Idorsia, Jazz, Janssen, Takeda, Merck, Neurocrine, Pernix, Sage, and Evecxia. CDB, RM, and MV are employees of Evidera, a firm contracted by Galderma to conduct the research. JP is an employee of Galderma.